These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1642759

  • 1. Tat and Kawasaki disease.
    Rautonen J, Rautonen N.
    Immunol Today; 1992 May; 13(5):190-1. PubMed ID: 1642759
    [No Abstract] [Full Text] [Related]

  • 2. Differential patterns of interaction between HIV type 1 and HTLV type I in monocyte-derived macrophages cultured in vitro: implications for in vivo coinfection with HIV type 1 and HTLV type I.
    Szabó J, Beck Z, Csomán E, Liu X, Andrikó I, Kiss J, Bácsi A, Ebbesen P, Tóth FD.
    AIDS Res Hum Retroviruses; 1999 Dec 10; 15(18):1653-66. PubMed ID: 10606088
    [Abstract] [Full Text] [Related]

  • 3. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.
    Dis Markers; 1990 Dec 10; 8(2):107. PubMed ID: 2201474
    [No Abstract] [Full Text] [Related]

  • 4. Reciprocal activation of human T-lymphotropic viruses in HTLV-I-transformed cells superinfected with HIV-1.
    De Rossi A, Saggioro D, Calabró ML, Cenzato R, Chieco-Bianchi L.
    J Acquir Immune Defic Syndr (1988); 1991 Dec 10; 4(4):380-5. PubMed ID: 2007972
    [Abstract] [Full Text] [Related]

  • 5. Antibodies in HIV Tat in Kawasaki disease.
    Rautonen N, White C, Martin NL, Wara DW, Salo E, Pelkonen P, Rautonen J.
    Lancet; 1994 Apr 09; 343(8902):920-1. PubMed ID: 7908382
    [No Abstract] [Full Text] [Related]

  • 6. Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
    Gatignol A, Jeang KT.
    Adv Pharmacol; 2000 Apr 09; 48():209-27. PubMed ID: 10987092
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative Interactome of HIV-1 Tat and Human T Lymphotropic Virus Type-1 Tax and the Cellular Transcriptional Machinery.
    Vandermeulen C, Hajingabo LJ, Twizere JC.
    AIDS Res Hum Retroviruses; 2015 Dec 09; 31(12):1204-5. PubMed ID: 26599333
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tat mediates transcriptional activation of HIV-1 gene in vitro.
    West M, Hoover T, Kung H, Raziuddin.
    Indian J Biochem Biophys; 1995 Dec 09; 32(6):351-5. PubMed ID: 8714203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
    Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F.
    Nature; 1990 May 03; 345(6270):84-6. PubMed ID: 2184372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.
    Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A.
    Nat Med; 2003 Feb 03; 9(2):191-7. PubMed ID: 12539042
    [Abstract] [Full Text] [Related]

  • 20. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB, Chang HK, Lisziewicz J, Su D, Murty LC, Ensoli B.
    Virology; 1996 Aug 01; 222(1):252-6. PubMed ID: 8806505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.